Narrow Gauge Ventures

About Narrow Gauge Ventures

Narrow Gauge Ventures is a venture capital firm focused on revolutionizing the healthcare sector by investing in companies that leverage digital systems to overcome the inefficiencies of the current healthcare system. They are dedicated to funding passionate entrepreneurs who create solutions that contribute to this transformation, particularly amid the opportunities presented by the recent complete overhaul of healthcare infrastructure. Recognizing the significant potential for improvement in the U.S. healthcare system, which is costly yet underperforming compared to other industrialized countries, Narrow Gauge Ventures identifies and invests in early- and middle-stage companies with strong teams, proven revenue, and sustainable, strategically capital-efficient growth. Their investment specialties include Pre-Seed and Seed rounds, with a minimum investment of $100,000, a maximum of $400,000, and a sweet spot of $150,000. Their sectors of interest encompass A.I. and Big Data, HealthTech and Fitness, Analytics, Medical Devices and Hospital Services, and Healthcare and Wellness, with a particular eye towards Woman-Focused innovations. Through their experience as investors and entrepreneurs in the digital health innovation wave, they offer resources and active support to their portfolio companies, assisting in their growth and success. The portfolio includes rMark Bio, which advances life sciences through products and tools; Agathos, that provides action-level insights to hospital physicians for improved care; Ripple, enhancing communication and collaboration in research; and Navv Systems, with an infrastructure-free location services platform for hospitals. Led by Jonathan Goldstein, a partner, entrepreneur, advisor, and investor, Narrow Gauge Ventures applies his operator's perspective to guide companies from seed to exit, aiming to fulfill the potential of entrepreneurs.